Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy
Marathon Pharma latest company to try for approval of Duchenne drug
BioPharma Dive
Wed, 06/15/16 - 05:43 pm
Marathon Pharma
Duchenne Muscular Dystrophy
3 Biotechs That Just Announced Successful Phase 2 Trials
24/7 Wall St
Sun, 06/12/16 - 10:03 pm
clinical trials
TEV-1845
Teva Pharmaceutical
migraines
Sarepta
eteplirsen
Duchenne Muscular Dystrophy
Sarepta Therapeutics: And Now We Wait
Barron's
Fri, 06/10/16 - 04:13 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
FDA’s Woodcock: ‘No connection’ between new drug access policy, Sarepta drug decision
Bizjournals.com
Fri, 06/3/16 - 09:52 pm
FDA
Sarepta Therapeutics
Janet Woodcock
Duchenne Muscular Dystrophy
eteplirsen
Sarepta sinks as FDA changes drug approval rules
CNBC
Thu, 06/2/16 - 04:08 pm
Sarepta Therapeutics
FDA
drug approvals
eteplirsen
Duchenne Muscular Dystrophy
Why BioMarin’s Bad News is Great for Sarepta
Barron's
Wed, 06/1/16 - 09:43 pm
Biomarin
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
drisapersen
BioMarin to Stop Developing its Duchenne Muscle Disease Drug
Bloomberg
Tue, 05/31/16 - 09:56 pm
Biomarin
Duchenne Muscular Dystrophy
Kyndrisa
Is the FDA’s decision to delay Sarepta drug decision good or bad? Nobody really knows
Marketwatch
Wed, 05/25/16 - 09:21 pm
Sarepta Therapeutics
FDA
Duchenne Muscular Dystrophy
eteplirsen
Sarepta Surges After U.S. Regulators Delay Ruling on DMD Drug
Bloomberg
Wed, 05/25/16 - 09:29 am
Sarepta Therapeutics
FDA
eteplirsen
Duchenne Muscular Dystrophy
Senators urge FDA to approve Sarepta drug for Duchenne
Stat
Tue, 05/24/16 - 11:12 am
Senate
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
2 End Of May FDA Decisions To Watch
Seeking Alpha
Mon, 05/23/16 - 07:03 pm
FDA
Sarepta Therapeutics
Titan Pharmaceuticals
Duchenne Muscular Dystrophy
eteplirsen
Probuphine
opioid addiction
2 Hotly Debated Drugs Due For FDA Decisions Next Week
Investors.com
Sat, 05/21/16 - 12:35 pm
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Intercept Pharma
Ocaliva
liver disease
primary biliary cholangitis
What's Sarepta Therapeutics Inc.'s Next Move?
Motley Fool
Tue, 05/10/16 - 09:43 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Wave to begin trials next year on 'more efficient' drug for Duchenne
Bizjournals.com
Mon, 05/9/16 - 01:52 pm
Wave Life Sciences
Duchenne Muscular Dystrophy
Sarepta: The Path Forward
Seeking Alpha
Wed, 05/4/16 - 08:52 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Why it took so long for Sarepta to start a big trial of its Duchenne drug
Bizjournals.com
Tue, 05/3/16 - 05:15 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
clinical trials
Sarepta Therapeutics shares surge 20% after article suggests drug approval possible
Marketwatch
Thu, 04/28/16 - 09:36 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
FDA
advisory panels
eteplirsen
Here Are Three Ways To Prevent Tragic Battles Between The FDA And Patients
Forbes
Wed, 04/27/16 - 09:06 am
FDA
patients
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
Biotech stock crashes 50% after disclosing bad news from the FDA
Yahoo/Business Insider
Tue, 04/26/16 - 09:45 am
Sarepta Therapeutics
eteplirsen
FDA
Duchenne Muscular Dystrophy
FDA panel votes against Sarepta’s drug for Duchenne muscular dystrophy
Stat
Mon, 04/25/16 - 09:57 pm
FDA
Sarepta Therapeutics
eteplirsen
advisory panels
Duchenne Muscular Dystrophy
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »